| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ae2c7cb1e6f8edf1d3dfe246d8ad21b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2875 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2017-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27bda1a3cbee9a991f3e07d1ec169420
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13bee6e5178d502456803b90f1e1bcd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87af1ad7f7198be62a1d26e40f9d34d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41d7f918bb35dfb48e838795682f0cd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a9d0e2918eeee899611b3ddcf9e4bb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be9ed6b50136a708ff59184938b5521b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b4f8c4f6100668d7778568fd1a3f0e1 |
| publicationDate |
2018-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018016331-A1 |
| titleOfInvention |
Methods of preventing or treating pain using anti-ngf antibodies |
| abstract |
Antibodies and antibody fragments thereof with binding specificity to human Nerve Growth Factor (NGF) and methods of use for treating pain. Methods of treating pain or eliciting an analgesic effect comprising administering an effective amount of an anti-human NGF antibody or antibody fragment thereof, which inhibits the association of NGF with TrkA, and/or p75. These methods may optionally further comprising administering an effective amount of a second anti-human NGF antibody or fragment thereof (e.g., one which inhibits the association of NGF with p75, or one that inhibits the association of NGF with TrkA.) |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113924315-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10323086-B2 |
| priorityDate |
2010-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |